
- $15,000
- Up To
Prendio is a complete eProcurement platform purpose-built for biotech, empowering fast-paced research teams with the tools they need to streamline purchasing, stay on budget, and accelerate discovery.
From lab supply requests to invoice approvals, Prendio simplifies and automates every step of the procure-to-pay process all in one intuitive system designed for science.
In time-critical research environments, there’s no room for clunky processes or outdated spreadsheets. Prendio replaces manual workarounds with smart workflows, giving scientists the autonomy to order what they need without getting bogged down in admin and giving finance and operations teams the visibility and control to manage spend with confidence.
Whether you’re a startup navigating your first round of funding or scaling toward the clinic, Prendio helps you:
Ditch the spreadsheet. Simplify procurement. Accelerate your science.
At Prendio, we believe scientists shouldn’t have to choose between driving research forward and managing purchase orders.
We exist to accelerate scientific discovery by eliminating the friction and inefficiencies of manual procurement. Built specifically for emerging biotech companies, Prendio streamlines the entire procure-to-pay process, giving both lab and finance teams the automation, visibility, and control they need to focus on what matters most: breakthrough innovation.
Traditional procurement tools weren’t designed with biotech in mind. Spreadsheets, email chains, disconnected systems, and vendor site hopping waste time, create errors, and slow down science. Prendio was made to change that.
Chroma Medicine is pioneering a new class of epigenetic medicines to revolutionize treatment of genetically driven disease. read more
The Machine Learning Immunology Company. We integrate machine learning across the entire discovery process. read more
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines. $CDAK read more
Founder & CEO of Centivax, computational immunoengineer read more